145 related articles for article (PubMed ID: 27379567)
21. Mycophenolate mofetil in multiple sclerosis.
Frohman EM; Brannon K; Racke MK; Hawker K
Clin Neuropharmacol; 2004; 27(2):80-3. PubMed ID: 15252268
[TBL] [Abstract][Full Text] [Related]
22. Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial.
Rathinam SR; Gonzales JA; Thundikandy R; Kanakath A; Murugan SB; Vedhanayaki R; Lim LL; Suhler EB; Al-Dhibi HA; Doan T; Keenan JD; Rao MM; Ebert CD; Nguyen HH; Kim E; Porco TC; Acharya NR;
JAMA; 2019 Sep; 322(10):936-945. PubMed ID: 31503307
[TBL] [Abstract][Full Text] [Related]
23. Mycophenolate mofetil for ocular inflammation.
Daniel E; Thorne JE; Newcomb CW; Pujari SS; Kaçmaz RO; Levy-Clarke GA; Nussenblatt RB; Rosenbaum JT; Suhler EB; Foster CS; Jabs DA; Kempen JH
Am J Ophthalmol; 2010 Mar; 149(3):423-32.e1-2. PubMed ID: 20042178
[TBL] [Abstract][Full Text] [Related]
24. [Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis].
Greiner K; Varikkara M; Santiago C; Forrester JV
Ophthalmologe; 2002 Sep; 99(9):691-4. PubMed ID: 12219257
[TBL] [Abstract][Full Text] [Related]
25. Association of systemic steroids and mycophenolate mofetil as rescue therapy for uveitic choroidal neovascularization unresponsive to the traditional immunosuppressants: interventional case series.
Neri P; Manoni M; Fortuna C; Lettieri M; Mariotti C; Giovannini A
Int Ophthalmol; 2010 Oct; 30(5):583-90. PubMed ID: 19727566
[TBL] [Abstract][Full Text] [Related]
26. Mycophenolate mofetil monotherapy in the management of paediatric uveitis.
Chang PY; Giuliari GP; Shaikh M; Thakuria P; Makhoul D; Foster CS
Eye (Lond); 2011 Apr; 25(4):427-35. PubMed ID: 21423146
[TBL] [Abstract][Full Text] [Related]
27. Mycophenolate mofetil therapy for inflammatory eye disease.
Thorne JE; Jabs DA; Qazi FA; Nguyen QD; Kempen JH; Dunn JP
Ophthalmology; 2005 Aug; 112(8):1472-7. PubMed ID: 16061096
[TBL] [Abstract][Full Text] [Related]
28. Periocular triamcinolone acetonide injections for control of intraocular inflammation associated with uveitis.
Salek SS; Leder HA; Butler NJ; Gan TJ; Dunn JP; Thorne JE
Ocul Immunol Inflamm; 2013 Aug; 21(4):257-63. PubMed ID: 23617776
[TBL] [Abstract][Full Text] [Related]
29. Mycophenolate mofetil for the treatment of uveitis.
Teoh SC; Hogan AC; Dick AD; Lee RW
Am J Ophthalmol; 2008 Nov; 146(5):752-60, 760.e1-3. PubMed ID: 18455143
[TBL] [Abstract][Full Text] [Related]
30. Quantitative Analysis of Uveitis Macular Edema in Multiple Sclerosis Patients Receiving Deep Posterior Sub-Tenon Triamcinolone Acetonide Injection.
Jovanović S; Šarenac Vulović T; Radotić F; Tončić Z; Živković M; Petrović N
Ophthalmic Res; 2017; 58(1):1-7. PubMed ID: 28324879
[TBL] [Abstract][Full Text] [Related]
31. Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis.
Zarbin MA; Jampol LM; Jager RD; Reder AT; Francis G; Collins W; Tang D; Zhang X
Ophthalmology; 2013 Jul; 120(7):1432-9. PubMed ID: 23531349
[TBL] [Abstract][Full Text] [Related]
32. Periocular corticosteroid injection in the management of uveitis in children.
Habot-Wilner Z; Sallam A; Roufas A; Kabasele PM; Grigg JR; McCluskey P; Lightman S
Acta Ophthalmol; 2010 Dec; 88(8):e299-304. PubMed ID: 21114631
[TBL] [Abstract][Full Text] [Related]
33. Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema.
Taylor SR; Habot-Wilner Z; Pacheco P; Lightman SL
Ophthalmology; 2009 Apr; 116(4):797-801. PubMed ID: 19344827
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic interventions for macular diseases show characteristic effects on near and distance visual function.
Munk M; Kiss C; Huf W; Sulzbacher F; Bolz M; Sayegh R; Eisenkölbl S; Simader C; Schmidt-Erfurth U
Retina; 2013 Oct; 33(9):1915-22. PubMed ID: 23584693
[TBL] [Abstract][Full Text] [Related]
35. The first investigation on differences in the effectiveness of mycophenolate mofetil and azathioprine antimetabolites determined in Polish patients treated for non-infectious uveitis.
Waszczyk-Łączak M; Łazicka-Gałecka M; Chomicz L; Mucha K; Pączek L; Szaflik JP
Ann Agric Environ Med; 2020 Dec; 27(4):644-649. PubMed ID: 33356073
[TBL] [Abstract][Full Text] [Related]
36. Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients.
Michel L; Vukusic S; De Seze J; Ducray F; Ongagna JC; Lefrère F; Jacq-Foucher M; Confavreux C; Wiertlewski S; Laplaud DA
J Neurol Neurosurg Psychiatry; 2014 Mar; 85(3):279-83. PubMed ID: 23704316
[TBL] [Abstract][Full Text] [Related]
37. Bilateral effect of unilateral ranibizumab in patients with uveitis-related macular edema.
Acharya NR; Sittivarakul W; Qian Y; Hong KC; Lee SM
Retina; 2011 Oct; 31(9):1871-6. PubMed ID: 21716165
[TBL] [Abstract][Full Text] [Related]
38. Mycophenolate Mofetil Therapy in Refractory Inflammatory Eye Disease.
Cuchacovich M; Solanes F; Perez C; Verdaguer JI; Verdaguer J; Castiglione E; Carpentier C; Traipe L; Villarroel F
J Ocul Pharmacol Ther; 2016; 32(1):55-61. PubMed ID: 26562247
[TBL] [Abstract][Full Text] [Related]
39. Long-term control of cystoid macular oedema in noninfectious uveitis with Mycophenolate Mofetil.
Neri P; Mariotti C; Cimino L; Mercanti L; Giovannini A
Int Ophthalmol; 2009 Jun; 29(3):127-33. PubMed ID: 18297240
[TBL] [Abstract][Full Text] [Related]
40. Combined fluocinolone acetonide intraocular delivery system insertion, phacoemulsification, and intraocular lens implantation for severe uveitis.
Chieh JJ; Carlson AN; Jaffe GJ
Am J Ophthalmol; 2008 Oct; 146(4):589-594. PubMed ID: 18639220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
